BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32271432)

  • 21. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
    Tan T; Xu XH; Lu XH; Wang XW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
    Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8893-8901. PubMed ID: 32964979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1.
    Xia LH; Yan QH; Sun QD; Gao YP
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5546-5553. PubMed ID: 30229827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis.
    Fang CL; Lin CC; Chen HK; Hseu YC; Hung ST; Sun DP; Uen YH; Lin KY
    Cancer Sci; 2018 Nov; 109(11):3438-3449. PubMed ID: 30168892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
    Wang T; Li W; Li W; Liu L; Zhang H
    J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
    Qiu HB; Yang K; Yu HY; Liu M
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression.
    Li XJ; Chen LW; Gao P; Jia YJ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12741-12747. PubMed ID: 33378022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating MLLT11.
    Zhang HP; Chen QK; Xu JF
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8902-8910. PubMed ID: 32964980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WT1 promotes invasion of NSCLC via suppression of CDH1.
    Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
    J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
    Shi XY; Lin JJ; Ge XJ; Shi Y
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
    Li Y; Xu J; Guo YN; Yang BB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
    Yu DJ; Li YH; Zhong M
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
    Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.